Results 1 to 10 of about 2,652 (202)

Experimental Treatment of Ebola Virus Disease with Brincidofovir. [PDF]

open access: yesPLoS ONE, 2016
BackgroundThe nucleotide analogue brincidofovir was developed to prevent and treat infections caused by double-stranded DNA viruses. Based on in vitro data suggesting an antiviral effect against Ebola virus, brincidofovir was included in the World Health
Jake Dunning   +15 more
doaj   +14 more sources

Assessment of three antiviral compounds against Borealpox virus infection in a mouse model [PDF]

open access: yesEmerging Microbes and Infections
Borealpox virus (BRPV) is a zoonotic orthopoxvirus which was first documented in Alaska in 2015. Although most human infections are mild, a recent fatal case in an immunocompromised individual highlights the importance of studying this emerging pathogen.
Jérémie Prévost   +7 more
doaj   +2 more sources

Antiviral Drugs for Treatment of Human Monkeypox: A Systematic Review/Meta-analysis [PDF]

open access: yesMicrobes, Infection and Chemotherapy
Background. On 23 July 2022, the World Health Organization declared a Public Health Emergency of International Concern. Monkeypox is a zoonotic viral disease caused by the monkeypox virus that is transmitted from animals to humans or from human to human.
Ahmed Mohamed Abdelghany   +2 more
doaj   +3 more sources

Successful Treatment of Adenovirus Infection with Brincidofovir in an Immunocompromised Patient after Hematological Stem Cell Transplantation [PDF]

open access: yesCase Reports in Infectious Diseases, 2020
Immunocompromised patients, including hematopoietic stem cell transplantation (HSCT), HIV, and malnourished patients, are at increased risk for viral infections with high incidences of morbidity and mortality.
T. Van Genechten   +3 more
doaj   +3 more sources

Oral Brincidofovir Therapy for Monkeypox Outbreak: A Focused Review on the Therapeutic Potential, Clinical Studies, Patent Literature, and Prospects

open access: yesBiomedicines, 2023
The monkeypox disease (MPX) outbreak of 2022 has been reported in more than one hundred countries and is becoming a global concern. Unfortunately, only a few treatments, such as tecovirimat (TCV), are available against MPX.
Mohd Imran   +2 more
exaly   +3 more sources

Preclinical activity of brincidofovir in peripheral T-cell and NK/T-cell lymphoma [PDF]

open access: yesBMC Medicine
Background Brincidofovir (BCV) is a novel nucleoside phosphonate analogue with unique dual antiviral and anti-tumor properties. Methods The activity of BCV was evaluated in 44 cell-line models, including T/NK-cell non-Hodgkin lymphoma (T/NK-NHL, n = 25 ...
Jason Yongsheng Chan   +18 more
doaj   +2 more sources

Disseminated Adenovirus Infection After Combined Liver-Kidney Transplantation [PDF]

open access: yesFrontiers in Cellular and Infection Microbiology, 2018
Human adenovirus (HAdV) infections are well-described after hematopoietic stem cell transplantation but less well understood in solid organ transplantation (SOT).
Marion Hemmersbach-Miller   +6 more
doaj   +3 more sources

Concurrent Mpox and HSV-1 Proctitis in a Young Male With AIDS: A Case Report of Treatment Failure [PDF]

open access: yesCase Reports in Infectious Diseases
Managing the mpox in patients with advanced HIV infection and coinfections poses significant challenges. This report discusses a young male with advanced HIV (CD4 count 28) and severe concurrent mpox and HSV-1 proctitis.
Mikhail Sukhoroslov   +5 more
doaj   +2 more sources

On topological co-index polynomials for predictive modeling of the physicochemical properties of antiviral drugs [PDF]

open access: yesScientific Reports
This study investigates the potential of topological co-indices and their polynomials as computational tools for predicting the physicochemical properties of antiviral compounds targeting the Ebola virus.
Summeira Meharban   +6 more
doaj   +2 more sources

Lactoferrin blocks orthopoxvirus entry via heparan sulphate and regulates host antiviral pathways [PDF]

open access: yesEmerging Microbes and Infections
Current antiviral therapies for orthopoxviruses face critical challenges, including limited efficacy and significant toxicity, which impede outbreak containment and clinical management.
Lili Tian   +15 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy